The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Amarin Corporation Plc (NASDAQ:AMRN) on Tuesday entered into an exclusive long-term license and supply agreement with Recordati S.p.A., Italy, to commercialize Vazkepa (icosapent ethyl) in 59 ...

(RTTNews) - Amarin Corporation plc (AMRN) Wednesday announced that Switzerland's Swissmedic has granted approval to Vazkepa. Swissmedic approved Vazkepa to reduce risk of cardiovascular events in ...

DUBLIN, Ireland and BRIDGEWATER, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that additional patient subgroup analyses from the landmark REDUCE-IT ...

Treatment will help reduce the risk of heart attacks and strokes for patients across Scotland Treatment will help reduce the risk of heart attacks and strokes for patients across Scotland Vazkepa, ...

Around 425,000 people in England and Wales with cardiovascular disease who are at risk of a secondary stroke or heart attack, could be eligible for treatment with Amarin's Vazkepa, following a NICE ...

Icosapent ethyl has been recommended by NICE for use across the NHS in England and Wales to reduce cardiovascular (CV) risk in adult statin-treated patients at high CV risk who have elevated ...

There’s a big change in Amarin’s (AMRN) C-Suite and it looks like the Street is not happy about it. Shares took a beating in Tuesday’s trading session after the biotech company announced the departure ...

SMC accepts VAZKEPA® (icosapent ethyl) to help reduce the risk of heart attacks and strokes for patients in Scotland 1 Icosapent ethyl has been accepted by the SMC for restricted use within ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended 13 new medicines for approval in its latest meeting. This includes AstraZeneca’s COVID-19 ...